# New weight loss pill that’s beating oral Ozempic

> **Newsylist Open Intelligence Dossier** · First detected: 2026-07-12 14:29 UTC · Category: Health · Sources: 5 · Current Velocity: 2.8

## Executive Summary
New oral GLP-1 receptor agonists are emerging as powerful alternatives to existing weight-loss medications in recent clinical trials.

## Intelligence Brief
Recent trial data indicates a new weight-loss pill has outperformed oral Ozempic. Specific medications mentioned in the coverage include Elecoglipron and Orforglipron, both of which are oral GLP-1 receptor agonists used for treating obesity and lowering blood glucose.


Coverage from ScienceDaily, NewsNation, and Qazinform focuses on the superiority of the new pill in a major trial. Technical details provided by Labmate Online and The New England Journal of Medicine highlight the use of a phase 2b trial for Elecoglipron.


Future developments depend on the results of these major trials and the ongoing evaluation of these oral small-molecule agonists as treatments for obesity.

## Verified Facts & Key Claims
### What are the names of the medications mentioned?
The coverage mentions Elecoglipron and Orforglipron.

### How did the new pill perform compared to oral Ozempic?
According to ScienceDaily and NewsNation, the new weight loss pill beat oral Ozempic in a major trial.

### What was the specific trial stage for Elecoglipron?
Elecoglipron was tested in a phase 2b trial.

## Key People, Organizations & Locations
GLP-1, Ozempic, Elecoglipron, Orforglipron, Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Qazinform | New weight-loss pill outperforms rival in major trial | 2026-07-11 17:13 | [Source Link](https://news.google.com/rss/articles/CBMikAFBVV95cUxQTl9kOEtlRUxHamsyaDhQbm9pd0l6RllBQWpuV2JTRHFmcV9DZ1JlX2paMEQ4aGZWMEdobXpVLVhxQ3dhdGFwWmVEU2lWQzRjalB2Qkc0RHN5d1h5Z3pJMVFESUVPMm1jWUh4dGlvbWVjeHdycExMalp6Z1lHNGZCVDBHMnU1T0F2MFRWM1JtVmfSAZABQVVfeXFMTjJrR2dMUXJxcjVmNFNHNlN0eEdLckNKTkRuV2tYZWRCRnY0bXFSWV82dFhQWUNvbkpYdXJrVGJtUHk0S3hmSVRlazMyVG9RMWpjNXBzdEdwcnFqd3BaZEZrMHNGX2Y0OGJCWGhsUmhvajBTUXNJRV9Rci1hOXlvelQ0UWsxMUVXS0F2bDRqZW14?oc=5) |
| Labmate Online | Elecoglipron, a GLP-1 tablet, lowers blood glucose and bodyweight in phase 2b trial | 2026-07-11 17:13 | [Source Link](https://news.google.com/rss/articles/CBMilwJBVV95cUxNcnhIRHhZMG1ic0pGMHY0eGdWWkpQZ0VMVjBQbjk2S0NZeUY5R3l2TUlIR3hYRTJIN1BqUENsOTg4TGc3RkVsaFd5bVhzZENfcEFSYks3ZGY2ejhWODltTjRRaGZRZks4NVJtVkstUEl2UzgyN0lHNE5GeVdOSllaY09MTXp6ZzVtNEFsaEFkV0hsbHJCby13T1RMT3hSRG1md3lwZjh6cnhJSEttSUdMTE9yWUlWWWtQVmFBcTM1Qm55Qk9EVHBYUi14UzNHQlpmZm56eFJKZ1JqUWlNNlVmMWJxdlVJb0ozbjdpRkYyeHQ5LW9XT3g1NlVweHpab1plNHd6bUk4QzNOQTlqRjJ3YUY4SFdGUlk?oc=5) |
| The New England Journal of Medicine | Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment | 2026-07-11 17:13 | [Source Link](https://news.google.com/rss/articles/CBMiYEFVX3lxTE9acWpiQ09pZjQwUHd0eDVIS25LRG8wTlFIWU1laXAyQ1h6ZmQ1NGp0dE1XWXprSzRnSnQ4a25jZEVDS1hHS3RSRm9kRVdKcHNvc1JQdWNfNnlEZG5ueDB1Mg?oc=5) |
| ScienceDaily | New weight loss pill beats oral Ozempic in major trial | 2026-07-11 17:13 | [Source Link](https://news.google.com/rss/articles/CBMib0FVX3lxTE1vd3dnX0Z0ZHdEdmI2dkZsbG54VkhGc1ZDSGFMLVdBekpoenpiVkotaXNKeW1OZkIydE5vRG5tUW1tVk0yYWZjWUdSbnpOZ19IdE44czhyY2VKQ29QWDJnNjJ3ZDhjdzlPQ2lsVkhfZw?oc=5) |
| NewsNation | New weight loss pill that’s beating oral Ozempic | 2026-07-11 17:13 | [Source Link](https://news.google.com/rss/articles/CBMijgFBVV95cUxPbnVLc1lGcC14SzQ5Wjh5Q2gxVjVUUFZXQVBxamJFLWdfa2RXbkt5UXFNYzVLOGJqTlE3NWxtXzRvU3h6SXNydGMxU0QzV2ppOHp0d0lPeXpZeVVnOExQc0FoNDNZRk1nandnbzk5S1ItWmF2ejB1aVp6WklMazhPZGc1TWc0MWI4aTgzRVh30gGTAUFVX3lxTE5JTTBZOWVzc3F2MW1CemNjRUtJTElNaUFUUERPZTZwSndZUmFLTWpNZFh4X0V5eF9zM25XbTJQNjVXb0hfTVFvbzJqczNicGpkTTh2WGJMcHZSZWI5TVRIdW9yLXFKQXdYX1VFSWVmaDRVaTJReVd3Z2xxSnVkck9QaWxiQUp6S2JrTmlxZ3ZwbFVuaw?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-07-12/new-weight-loss-pill-that-s-beating-oral-ozempic*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*